ZNF79 and obstructive sleep apnea syndrome: More significantly, PAI showed that after systemic administration, both PGNR-PT6 and PGNR-PT7 could specifically attach to subcutaneous UMR-106 xenografts and increase the contrast of OSA pictures by 170% and 230%, respectively in tumor-bearing mice.